The effectiveness of HN antibody counseling and testing as a prevention int
ervention is limited: persons testing seronegative do not usually change th
eir risk behaviors, some actually increase their risk behaviors, and decrea
ses in risk behaviors are usually short-lived. Referrals to additional prev
ention and other needed services are therefore recommended, although the ex
tent and determinants of referral provision for persons testing seronegativ
e are unknown. We assessed the prevalence of referrals and the association
between risk behaviors and prevention referrals among seronegatives. We rev
iewed HIV testing and referral data on all persons receiving confidential s
eronegative test results in San Francisco (SF) in the first 10 months of 19
95 (n = 5,595), and gathered more detailed referral information at the muni
cipal STD clinic from November 1995 through May 1996 (n = 747). The overall
prevalence of referrals was low: a referral was given to 19.1% of the SF s
ample and 10.6% of the STD clinic sample; 15.4% of the SF sample and 5.9% o
f the STD clinic sample received a prevention referral. Injection drug user
s (IDUs) were the most likely to receive a prevention referral (48.5% of SF
IDUs, 36.4% of STD clinic IDUs); men having sex with men and women with hi
gh-risk partners were also more likely to get a prevention referral than ot
hers. For SF IDUs, unsafe sex and needle sharing were not associated with a
n increased likelihood of receiving a prevention referral. Opportunities to
link high-risk clients from counseling and testing to HIV prevention servi
ces are being missed. The referral component of HIV counseling and testing
should be improved.